{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:00:43Z","timestamp":1777539643209,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jpha.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,11,28]],"date-time":"2015-11-28T04:17:34Z","timestamp":1448684254000},"page":"112-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Liquid chromatography\u2013tandem mass spectrometry method for simultaneous determination of valproic acid and its ene-metabolites in epilepsy patient plasma"],"prefix":"10.1016","volume":"6","author":[{"given":"Huan","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingkai","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2015.11.006_bib1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpha.2015.11.006_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpha.2015.11.006_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3109\/00498258709167407","article-title":"Studies on the metabolic fate of valproic acid in the rat using stable isotope techniques","volume":"17","author":"Rettenmeier","year":"1987","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpha.2015.11.006_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1528-1157.1984.tb05632.x","article-title":"Valproic acid and metabolites: pharmacological and toxicological studies","volume":"25","author":"Nau","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpha.2015.11.006_bib5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.1840040609","article-title":"The hepatotoxicity of valproic acid and its metabolites in rats.I. Toxicologic, biochemical and histopathologic studies","volume":"4","author":"Kesterson","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.jpha.2015.11.006_bib6","first-page":"475","article-title":"Determination of valproates in serum by TLC after derivatization","volume":"21","author":"Guo","year":"2001","journal-title":"Chin. J. Hosp. Pharm."},{"key":"10.1016\/j.jpha.2015.11.006_bib7","first-page":"519","article-title":"Determination of CAR VAP by rat nephelometric inhibition immunoassay","volume":"21","author":"Jing","year":"2001","journal-title":"Chin. J. Hosp. Pharm."},{"key":"10.1016\/j.jpha.2015.11.006_bib8","first-page":"674","article-title":"Simultaneous determination of the concentrations of valproate and topiramate in human plasma by GC method","volume":"30","author":"Tang","year":"2010","journal-title":"Chin. J. Hosp. Pharm."},{"key":"10.1016\/j.jpha.2015.11.006_bib9","first-page":"25","article-title":"Determination of sodium valproate in human serum by HPLC","volume":"18","author":"Zhan","year":"2009","journal-title":"Chin. Pharm."},{"key":"10.1016\/j.jpha.2015.11.006_bib10","first-page":"150","article-title":"Simultaneous determination of carbamazepineand sodium valproate in serum by RP-HPLC","volume":"10","author":"Li","year":"2010","journal-title":"Eval. Anal. Drug. Use. Hosp. Chin."},{"key":"10.1016\/j.jpha.2015.11.006_bib11","first-page":"3204","article-title":"Effects of influence factors on derivation of serum concentration of sodium valproat by HPLC","volume":"21","author":"Zhang","year":"2010","journal-title":"Chin. Pharm."},{"key":"10.1016\/j.jpha.2015.11.006_bib12","first-page":"27","article-title":"Determination of sodium valproate in serum by HPLC after precolumn derivatization","volume":"13","author":"Li","year":"2004","journal-title":"Chin. J. Hosp. Pharm."},{"key":"10.1016\/j.jpha.2015.11.006_bib13","first-page":"32","article-title":"Determination of the concentration of valproic acid in serum with RP-HPLC","volume":"13","author":"He","year":"2002","journal-title":"Chin. Pharm."},{"key":"10.1016\/j.jpha.2015.11.006_bib14","first-page":"296","article-title":"Determination of valproic acid in serum by high performance liquid chromatography","volume":"9","author":"Chen","year":"2000","journal-title":"Chin. J. Clin. Med."},{"key":"10.1016\/j.jpha.2015.11.006_bib15","first-page":"817","article-title":"HPLC\u2013MS\/ESI determination of valproic acid in human serum","volume":"25","author":"Zhu","year":"2005","journal-title":"Chin. J. Pharm. Anal."},{"key":"10.1016\/j.jpha.2015.11.006_bib16","unstructured":"Z. Chen, Z. Fang, X. Wang, et al., The establishment of analytical methods to determinate sodium valproate in human plasma and its toxic metabolite by HPLC, The 12th National Congress of Clinical Pharmacology, Wuhan, 2010"},{"key":"10.1016\/j.jpha.2015.11.006_bib17","first-page":"1356","article-title":"LC\u2013ESI\u2013MS determination of sodium valproate in human plasma","volume":"20","author":"Yang","year":"2010","journal-title":"Chin. J. Health Lab. Technol."},{"key":"10.1016\/j.jpha.2015.11.006_bib18","unstructured":"S. Gao, H. Miao, W. Chen, LC\u2013MS\/MS method for simultaneous determination of valproic acid and majaor metabolites in human plasma, The 2011 Congress of Chinese pharmaceutical and 11th Chinese Medicine week, Yantai, 2011, pp. 1\u201317"},{"key":"10.1016\/j.jpha.2015.11.006_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchromb.2014.03.033","article-title":"Small molecule adduct formation with the components of the mobile phase as a way to analyse valproic acid in human serum with liquid chromatography\u2013tandem mass spectrometry","volume":"959","author":"Dziadosz","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpha.2015.11.006_bib20","first-page":"212","article-title":"Analysis of variability of concentrations of valproic acid (VPA) and its selected metabolites in the blood serum of patients treated with VPA and patients hospitalized because of VPA poisoning","volume":"64","author":"Wilimowska","year":"2014","journal-title":"Arch. Med. Sadowej Kryminol."},{"key":"10.1016\/j.jpha.2015.11.006_bib21","unstructured":"FDA, Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CV), 2001."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177915300174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177915300174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:28:16Z","timestamp":1761859696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177915300174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S2095177915300174"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2015.11.006","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid chromatography\u2013tandem mass spectrometry method for simultaneous determination of valproic acid and its ene-metabolites in epilepsy patient plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}